Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study
Open Access
- 11 February 2010
- journal article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 31 (6) , 1036-1041
Abstract
BACKGROUND AND PURPOSE: Longitudinal MR imaging measures provide an opportunity to track progression in HD before the emergence of clinical symptoms. This may prove useful in assessing disease-modifying treatments. We investigated how caudate and global volumes change as HD progresses from premanifest to early disease. MATERIALS AND METHODS: Forty HD gene-positive individuals and 19 controls underwent serial volumetric MR imaging (baseline, 12 and 27 months; 2 or 3 scans per person). At baseline, 3 patients with HD were premanifest but developed overt motor features during the study, and 37 had early HD. All had dates of motor onset recorded. Caudates, lateral ventricles, and TIVs were measured using semiautomated procedures. Linear mixed models were used to investigate differences between HD and controls in relation to motor onset, controlling for TIV, sex, and age. RESULTS: Extrapolating backwards in time, we found that differences in caudate and ventricular volumes between patients with HD and controls were evident 14 and 5 years, respectively, before motor onset (P < .05). At onset, caudate volume was 2.58 mL smaller than that in controls (P < .0001); ventricular volume was 9.27 mL larger (P < .0001). HD caudate atrophy rates were linear, showed low variability between subjects, and were approximately 10-fold higher than those in controls (P < .001). HD ventricular enlargement rates were variable between subjects, were approximately 4-fold higher than those in controls at onset (P < .001), and accelerated with disease duration (P = .02). CONCLUSIONS: We provide evidence of acceleration of global atrophy in HD with disproportionate caudate involvement. Both caudate and global measures may be of use as early markers of HD pathology.Keywords
This publication has 18 references indexed in Scilit:
- Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's diseaseNeuroImage, 2009
- Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's diseaseMovement Disorders, 2009
- Distinct Brain Volume Changes Correlating with Clinical Stage, Disease Progression Rate, Mutation Size, and Age at Onset Prediction as Early Biomarkers of Brain Atrophy in Huntington's DiseaseCNS Neuroscience & Therapeutics, 2009
- Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneityBrain, 2008
- Change in MRI striatal volumes as a biomarker in preclinical Huntington's diseaseBrain Research Bulletin, 2007
- Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeatBrazilian Journal of Medical and Biological Research, 2006
- Preparing for Preventive Clinical TrialsArchives of Neurology, 2006
- Pharmaceutical, cellular and genetic therapies for Huntington's diseaseClinical Science, 2005
- Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer diseaseNeurology, 2005
- Onset and rate of striatal atrophy in preclinical Huntington diseaseNeurology, 2004